Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Morphine Drugs Global Market Report 2025
Request Sample Buy Now
Global Morphine Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Morphine Drugs Global Market Report 2025

By Dosage form (Injectable, Oral, Other Dosage Forms), By Distribution channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Applications (Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Cold And Cough Suppressant, Other Applications), By End Users (Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Morphine Drugs Market Overview

• Morphine Drugs market size has reached to $21.82 billion in 2024

• Expected to grow to $28.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Increasing Prevalence Of Chronic Pain Driving Growth Of Morphine Drug Market

• Market Trend: Advancements in Morphine Sulfate Injection

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Morphine Drugs Market?

Morphine drugs refer to a class of medications that contain morphine, a potent opioid analgesic (pain reliever) derived from the opium poppy plant. They are used for relieving moderate to severe pain, commonly after surgery or injury, or in treating conditions like cancer.

The main dosage forms of morphine drugs are injectable, oral, and other dosage forms. Injectables are medications or substances that are formulated to be administered into the body via injection, bypassing the digestive system for immediate effect. The various distribution channels include hospital pharmacy, retail pharmacy, and online pharmacy used for various applications such as pain management, palliative care, diarrhea suppressant, anesthesia, cold and cough suppressant, and others and used by various end users such as hospitals and clinics, ambulatory surgical centers, and others.

Morphine Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Morphine Drugs Market Size 2025 And Growth Rate?

The morphine drugs market size has grown strongly in recent years. It will grow from $21.82 billion in 2024 to $23.09 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in the number of cancer cases, rise in prevalence of orthopedic diseases, rise in number of surgical procedures, rise in the aging population, and a rise in healthcare expenditure.

What Is The Morphine Drugs Market Growth Forecast?

The morphine drugs market size is expected to see strong growth in the next few years. It will grow to $28.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to an increase in cancer cases, increasing prevalence of pain conditions, growing awareness of palliative care, rising prevalence of chronic disorders, and increased use of opioids. Major trends in the forecast period include technological advancements in drug formulation, integration of digital health solutions, integration of technology, collaborations and partnerships, and implantable medical devices.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. palliative care centers by driving up the cost of opioid alkaloid extracts and abuse-deterrent formulation technologies sourced from the UK and Australia, exacerbating pain management challenges and increasing controlled substance monitoring costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Morphine Drugs Market Segmented?

1) By Dosage form: Injectable, Oral, Other Dosage Forms

2) By Distribution channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Applications: Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Cold And Cough Suppressant, Other Applications

4) By End Users: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Injectable: Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection

2) By Oral: Oral Tablets (Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules)

3) By Other Dosage Forms: Rectal Suppositories, Transdermal Patches, Sublingual Tablets Or Films

What Is Driving The Morphine Drugs Market? Increasing Prevalence Of Chronic Pain Driving Growth Of Morphine Drug Market

The increasing prevalence of chronic pain conditions is expected to propel the growth of the morphine drugs market going forward. Chronic pain is a complex condition characterized by persistent discomfort that lasts for an extended period, which serves as a warning signal of injury or illness. Chronic pain has grown into a serious health concern globally due to several interrelated variables, such as aging populations, rising obesity rates, sedentary lifestyles, stress and mental health difficulties, and environmental factors. Morphine is necessary to control chronic pain as IT is highly effective in relieving pain and may be customized to meet the specific demands of each patient. It enhances life quality and enables those who suffer from chronic pain to achieve more without experiencing excruciating pain all the time. For instance, in May 2021, according to the Government of Canada, a Canada-based federal administration, up to 8.3 million Canadians may experience chronic pain by 2025, and IT is expected to reach up to 9.0 million by 2030. Therefore, the increasing prevalence of chronic pain conditions is driving the growth of the morphine drug industry.

Who Are The Major Players In The Global Morphine Drugs Market?

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA

What Are The Key Trends Of The Global Morphine Drugs Market? Advancements in Morphine Sulfate Injection

Major companies operating in morphine drug market are developing morphine sulfate injection to advance the offerings of medical treatment. Morphine sulfate injection is a powerful opioid analgesic used to manage severe pain. It is derived from opium and works by binding to the opioid receptors in the brain and spinal cord, altering the perception and emotional response to pain. For instance, Hospira, a US-based pharmaceutical and medical device company, added Morphine Sulfate Injection, which is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. The product is available in various strengths and formulations, including a preservative-free version for intravenous, epidural, or intrathecal use. The labeling information highlights the risks associated with Morphine Sulfate Injection, including addiction, abuse, and misuse, as well as serious and life-threatening risks from its use.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Morphine Drugs Market? Bora Pharmaceuticals Inc. Acquires Upsher-Smith Laboratories Inc. To Enhance Position In Generics Market

In January 2024, CDMO Bora Pharmaceuticals Inc., a Taiwan-based pharmaceutical company, acquired Upsher-Smith Laboratories Inc. for $210 million. Through this acquisition, Bora aims to strengthen its position in the generics market, potentially expanding its product range, improving manufacturing capacity, fostering innovation, and exploring entry into new geographic markets. Upsher-Smith Laboratories Inc. is a US-based pharmaceutical company that manufactures morphine drugs.

What Is The Regional Outlook For The Global Morphine Drugs Market?

North America was the largest region in the morphine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Morphine Drugs Market?

The morphine drugs market consists of sales of morphine sulfate, Roxanol oral solution, Kadian capsules, morphine injections, and Avinza capsules. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Morphine Drugs Industry?

The morphine drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the morphine drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Morphine Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $23.09 billion
Revenue Forecast In 2034 $28.86 billion
Growth Rate CAGR of 5.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Dosage form: Injectable, Oral, Other Dosage Forms
2) By Distribution channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Applications: Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Cold And Cough Suppressant, Other Applications
4) By End Users: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Injectable: Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection
2) By Oral: Oral Tablets ( Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules)
3) By Other Dosage Forms: Rectal Suppositories, Transdermal Patches, Sublingual Tablets Or Films
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Morphine Drugs Market Characteristics

3. Morphine Drugs Market Trends And Strategies

4. Morphine Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Morphine Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Morphine Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Morphine Drugs Market Growth Rate Analysis

5.4. Global Morphine Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Morphine Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Morphine Drugs Total Addressable Market (TAM)

6. Morphine Drugs Market Segmentation

6.1. Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable

Oral

Other Dosage Forms

6.2. Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

6.3. Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pain Management

Palliative Care

Diarrhea Suppressant

Anesthesia

Cold And Cough Suppressant

Other Applications

6.4. Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Surgical Centers

Other End Users

6.5. Global Morphine Drugs Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Morphine Sulfate Injection

Morphine Hydrochloride Injection

Morphine Extended Release Injection

6.6. Global Morphine Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets (Immediate-Release, Extended-Release)

Oral Solution Or Syrup

Oral Capsules (Extended-Release Capsules)

6.7. Global Morphine Drugs Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Rectal Suppositories

Transdermal Patches

Sublingual Tablets Or Films

7. Morphine Drugs Market Regional And Country Analysis

7.1. Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Morphine Drugs Market

8.1. Asia-Pacific Morphine Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Morphine Drugs Market

9.1. China Morphine Drugs Market Overview

9.2. China Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Morphine Drugs Market

10.1. India Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Morphine Drugs Market

11.1. Japan Morphine Drugs Market Overview

11.2. Japan Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Morphine Drugs Market

12.1. Australia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Morphine Drugs Market

13.1. Indonesia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Morphine Drugs Market

14.1. South Korea Morphine Drugs Market Overview

14.2. South Korea Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Morphine Drugs Market

15.1. Western Europe Morphine Drugs Market Overview

15.2. Western Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Morphine Drugs Market

16.1. UK Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Morphine Drugs Market

17.1. Germany Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Morphine Drugs Market

18.1. France Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Morphine Drugs Market

19.1. Italy Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Morphine Drugs Market

20.1. Spain Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Morphine Drugs Market

21.1. Eastern Europe Morphine Drugs Market Overview

21.2. Eastern Europe Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Morphine Drugs Market

22.1. Russia Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Morphine Drugs Market

23.1. North America Morphine Drugs Market Overview

23.2. North America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Morphine Drugs Market

24.1. USA Morphine Drugs Market Overview

24.2. USA Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Morphine Drugs Market

25.1. Canada Morphine Drugs Market Overview

25.2. Canada Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Morphine Drugs Market

26.1. South America Morphine Drugs Market Overview

26.2. South America Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Morphine Drugs Market

27.1. Brazil Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Morphine Drugs Market

28.1. Middle East Morphine Drugs Market Overview

28.2. Middle East Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Morphine Drugs Market

29.1. Africa Morphine Drugs Market Overview

29.2. Africa Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Morphine Drugs Market Competitive Landscape And Company Profiles

30.1. Morphine Drugs Market Competitive Landscape

30.2. Morphine Drugs Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Rusan Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Morphine Drugs Market Other Major And Innovative Companies

31.1. Daiichi Sankyo Company Limited

31.2. Sandoz AG

31.3. Viatris Inc.

31.4. Dr. Reddy's Laboratories Ltd.

31.5. Apotex Inc.

31.6. Hikma Pharmaceuticals PLC

31.7. Endo Pharmaceuticals Inc.

31.8. Sun Pharmaceutical Industries Ltd.

31.9. Johnson Matthey Fine Chemicals

31.10. Fresenius Kabi USA LLC

31.11. Delpharm SaS

31.12. Alvogen Inc.

31.13. Mallinckrodt Pharmaceuticals

31.14. Lannett Company

31.15. Mayne Pharma Group Limited

32. Global Morphine Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Morphine Drugs Market

34. Recent Developments In The Morphine Drugs Market

35. Morphine Drugs Market High Potential Countries, Segments and Strategies

35.1 Morphine Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Morphine Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Morphine Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Morphine Drugs Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Morphine Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Morphine Drugs Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Sanofi S.A. Financial Performance
  • Table 80: Rusan Pharma Ltd. Financial Performance
  • Table 81: Johnson & Johnson Financial Performance
  • Table 82: Teva Pharmaceutical Industries Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Morphine Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Morphine Drugs Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Morphine Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Morphine Drugs Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Morphine Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Morphine Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Morphine Drugs Market, Segmentation By Dosage form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Morphine Drugs Market, Segmentation By Distribution channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Morphine Drugs Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Sanofi S.A. Financial Performance
  • Figure 80: Rusan Pharma Ltd. Financial Performance
  • Figure 81: Johnson & Johnson Financial Performance
  • Figure 82: Teva Pharmaceutical Industries Ltd. Financial Performance

Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Non-Steroidal Anti-inflammatory Drugs Industry

Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Non-Therapeutic Biomolecules Market: Key Developments and Future Strategies to 2029

Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Read More About Global Pain Management Drugs Market Forecast to Reach $104.19 Billion by 2029, Driven by 5.6% CAGR

Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

Read More About Pericarditis Industry Poised for Rapid Expansion, Projected to Hit $3.37 Billion by 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cell Banking Outsourcing Global Market Report 2025 – By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), By Cell Type (Stem Cell Banking, Non-Stem Cell Banking), By Phase (Bank Storage, Bank Characte...

View Report

Laryngeal Cancer Therapeutics Global Market Report 2025 – By Treatment Type (Chemotherapy, Immunotherapy, Other Treatments), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Onli...

View Report

Deep Frozen Packaging Logistics Global Market Report 2025 – By Type (Air Transport, Land Transport, Maritime Transport), By Materials (Clinical Trials, Cell And Gene Therapies, Reagents, Cell Culture Media), By Applicati...

View Report

Headset Global Market Report 2025 – By Type (In-Ear, Over Ear), By Price Band (Below USD 50, USD 51-150, USD 151-350, Over USD 351), By Connectivity (Wired, Wireless), By Application (Smartphone, Personal Computer (PC), ...

View Report

Terminal Tractor Global Market Report 2025 – By Type (Manual, Automated), By Propulsion (Diesel, Compressed Natural Gas (CNG), Hybrid, Electric), By Tonnage (Less Than 50 Ton, 50-100 Ton, Greater Than 100 Ton), By Axle (...

View Report

Plastic Paint Global Market Report 2025 – By Type (Vinyl Paint, Rubber Paint, Acrylic Paint), By Process (Dip Coating, Spray Coating, Powder Coating, Electrophoretic Painting, Other Process), By Application (Household, C...

View Report

Gastrointestinal Drugs Market 2022 - By Type (Antacids, Antiulcerants, Antiemetics and Antinauseants, Antidiarrheals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Root of Administrat...

View Report

Frequently Asked Questions

Morphine drugs refer to a class of medications that contain morphine, a potent opioid analgesic (pain reliever) derived from the opium poppy plant. They are used for relieving moderate to severe pain, commonly after surgery or injury, or in treating conditions like cancer. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Chronic Pain Driving Growth Of Morphine Drug Market. For further insights on this market, request a sample here

The morphine drugs market size has grown strongly in recent years. It will grow from $21.82 billion in 2024 to $23.09 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in the number of cancer cases, rise in prevalence of orthopedic diseases, rise in number of surgical procedures, rise in the aging population, and a rise in healthcare expenditure. The morphine drugs market size is expected to see strong growth in the next few years. It will grow to " $28.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to an increase in cancer cases, increasing prevalence of pain conditions, growing awareness of palliative care, rising prevalence of chronic disorders, and increased use of opioids. Major trends in the forecast period include technological advancements in drug formulation, integration of digital health solutions, integration of technology, collaborations and partnerships, and implantable medical devices. For further insights on this market, request a sample here

The morphine drugs market covered in this report is segmented –
1) By Dosage form: Injectable, Oral, Other Dosage Forms
2) By Distribution channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Applications: Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Cold And Cough Suppressant, Other Applications
4) By End Users: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users Subsegments:
1) By Injectable: Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection
2) By Oral: Oral Tablets ( Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules)
3) By Other Dosage Forms: Rectal Suppositories, Transdermal Patches, Sublingual Tablets Or Films For further insights on this market, request a sample here

North America was the largest region in the morphine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the morphine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA . For further insights on this market, request a sample here.

Major trends in this market include Advancements in Morphine Sulfate Injection. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Morphine Drugs Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon